Full-Time

Cardiac PET Account Manager

Posted on 12/13/2025

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

Compensation Overview

$144.9k - $217.3k/yr

+ Performance-based incentive + Cash bonus(es) + Long-term incentives

United States

Hybrid

Requires up to 30% overnight travel; relocation assistance provided.

Category
Sales & Account Management (1)
Required Skills
Sales
Forecasting
Cold Calling
Data Analysis
Requirements
  • Bachelor's degree from an accredited university or college or certification through the NMTCB or AART
  • 5+ years of sales experience in a healthcare facility, including contracting and calling on physicians and office staff. Proven history of sales success, developing, organizing, and implementing territory plans, meeting and exceeding sales targets, and penetrating new accounts/markets/competition through proficiency in prospecting, lead qualification, sales, and negotiations.
  • Experience selling/leading in a highly matrixed environment and large account management preferred.
  • Willing to reside in the territory and execute at least 30% overnight travel based on business needs and some weekends, as is typical with trade show attendance.
Responsibilities
  • Develop and execute a territory business plan to drive Flyrcado market share growth, partnering with Hospitals, Imaging Centers, Cardiac Centers, Mobile Imaging, DOD, and VA facilities to offer Flyrcado.
  • The plan will identify business and functional relationships within Imaging and Cardiology's key referral sources and model competitive threats to Flyrcado adoption.
  • Through customer insights, leverage the knowledge of influence networks & affiliations (i.e., Payers, societies) to realize business objectives.
  • This should lead to achieving or exceeding Flyrcado sales forecasts and shared volume targets.
  • With your Cardiac PET Physician Outreach teammate, conduct regular business analyses of the local market—customers, payers, competition, and key stakeholders creating, implementing, and updating business plans to achieve access and sales goals.
  • Accountable to achieve the quarterly and yearly Operating Plan for the territory, customer satisfaction, and retention.
  • Understand product differentiators and position Flyrcado as the product of choice through high clinical acumen and routine use of Marketing Assets and Education Programs to create awareness of Flyrcado.
  • Be a trusted advisor to Imaging Centers and Cardiologists by deepening your understanding of their goals, equipment, and workflow. This will help you help customers navigate the Cardiac PET marketplace, including how to implement Flyrcado in their facility.
  • Identify the top referring Cardiologists, create relationships, and appropriately impact the decision-making criteria to help increase awareness and utilization of Flyrcado.
  • Prioritize multiple projects and drive focus on high-impact opportunities; monitor Performance Dashboards to analyze, interpret, and execute actionable sales efforts; prioritize customers and assign responsibilities.
  • Collaborate with market access support teams to optimize payor contract implementation and satisfaction across imaging centers and hospitals.
  • Collaborate with pharmacy channel partners and GE PDx Application Specialists teams to meet the customer’s product delivery goals, education needs, and expectations.
  • Pre-call planning and in-call questioning to understand customer needs, craft solutions, and drive utilization.
  • Monitor territory plan performance and results and collaborate on next action steps with cross-functional internal and external partners.
  • Virtual selling and cold calling to new and existing targets. Wherever possible, live meetings with customers are expected.
  • Providing pricing strategy, price negotiation, and contract management and ensuring pricing compliance for segment opportunities
  • Forecasting orders and sales of assigned territory and submitting weekly progress reports.
  • Representing the company at healthcare conferences and seminars to promote GEHC products and the company.
  • Understand the goals and clinical benefits of GE HealthCare’s HCS and National team and drive total business to GE HealthCare where appropriate.
  • Ensure a compliant, ethical culture to promote GEHC products and adhere to the highest standards.
  • Additional projects and initiatives as required.
Desired Qualifications
  • Nuclear Medicine and Nuclear Cardiac Industry acumen.
  • Experience with product launch and P&T Committees preferred.
  • Strong analytical, oral, presentation, and written skills; proficient in MS Office and CRM.
  • Ability to work independently and with a team to manage multiple stakeholders and competing priorities through effective organizational, people, and time management skills.
  • Ability to mentor non-senior CPAMs as requested by leadership and manage special projects within commercial.
  • Analytical ability to use internal reporting to manage account plans and identify patterns and opportunities for growth.
  • Ability to apply various traditional and nontraditional problem-solving techniques to solve complex issues creatively to improve performance and company effectiveness.
  • Ability to build rapport and relationships by interacting effectively with employees and external contacts (i.e., MD and office staff) at all levels, demonstrating awareness of their needs and responding appropriately.
  • Ability to achieve objectives while operating in compliance with regulatory guidelines.
  • Prior experience selling into Academic Institutions

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Simplify Jobs

Simplify's Take

What believers are saying

  • $2.3B Intelerad acquisition boosts cloud imaging amid $5.1B Q1 2026 revenue.
  • DeepHealth AI partnership lifts breast cancer detection 21% globally.
  • $21.8B backlog and supply chain shifts sustain 3-4% organic growth.

What critics are saying

  • Siemens Cios Alpha erodes CT share with superior resolution by Q2 2027.
  • Canon Vantage Galan captures MRI contracts 20-30% cheaper in 6-12 months.
  • FTC probe forces Intelerad divestitures, costing $300-500M by Q1 2027.

What makes GE Healthcare unique

  • GE HealthCare's four divisions span imaging, ultrasound, patient care, and pharmaceutical diagnostics.
  • Bangalore's $50M R&D center drives innovations across 100+ countries.
  • Photonova Spectra's Deep Silicon detectors enable 8-bin energy resolution CT imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.

INACTIVE